Outcome of the Board Meeting dated 14th November 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zodiac Ventures' board approved unaudited standalone and consolidated results for Q2 and H1 FY26 (ended 30 Sept 2025). Standalone revenue from operations rose sharply to Rs. 129.76 lakhs in H1 FY26 vs Rs. 59.15 lakhs in H1 FY25 (over 2x growth), driven mainly by Q2 sales of Rs. 66.09 lakhs. Standalone profit after tax for H1 stood at Rs. 57.59 lakhs (vs Rs. 43.62 lakhs), though Q2 PAT dipped to Rs. 28.55 lakhs from Rs. 43.91 lakhs due to higher finance and other expenses. A Rights Issue of 4.51 crore shares at Rs. 6.30 each (including premium) was completed on 3 September 2025, raising roughly Rs. 28.4 crore and increasing paid-up capital from Rs. 3.76 crore to Rs. 8.27 crore. A new residential project 'Zodiac Guruchhaya' at Vile Parle East commenced on 14 July 2025, with estimated sales potential of about Rs. 110 crore. Auditor (Pravin Chandak & Associates) issued an unmodified review report with no qualifications or emphasis matters. However, operating cash flow was deeply negative at Rs. (1,805.51) lakhs in H1, largely due to inventory and other asset build-up, with cash position only sustained by the rights issue proceeds.
The strong top-line growth and successful Rs. 28 crore rights issue strengthen the balance sheet for the company's new real estate project, but the steep fall in Q2 profit and large negative operating cash flow signal execution and cost pressure. Short-term stock reaction may depend on how investors weigh fresh funding for a new Rs. 110 crore project against weak cash conversion and rising finance costs.